Biologics
Thermo Fisher Scientific and CZ Imaging Institute Forge Alliance to Advance High-Resolution Cellular Imaging
New alliance for advanced biological imaging aimed at enhancing some of the world's most innovative structural cell biology capabilities to help scientists...
March 28, 2025 | News
Turn Bio Acquires ARMMs Technology to Advance Precision Epigenetic Therapies Across More Tissues and Indications
ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can delive...
March 27, 2025 | News
AnHorn Medicines Doses First Subject in U.S. Phase I Trial for AH-001, a First-in-Class Protein Degrader Targeting Hair Loss
AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androg...
March 27, 2025 | News
Complete Genomics and BioTuring Partner to Accelerate Spatial Transcriptomics with AI-Powered Analysis Tool
Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has pa...
March 26, 2025 | News
SineuGene Therapeutics Receives FDA IND Clearance for First-in-Class ALS Gene Therapy SNUG01
SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, announce...
March 25, 2025 | News
Sermonix and Regor Therapeutics Forge Strategic Alliance to Advance Targeted Therapies for Metastatic Breast Cancer
Sermonix Pharmaceuticals, a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mB...
March 25, 2025 | News
Thermo Fisher Scientific Launches Next-Gen HLA Typing Kit to Advance Immunogenetics Research
To enable human leukocyte antigen (HLA) scientists and researchers to continue to advance research of histocompatibility and immunogenetics, Thermo Fisher ...
March 25, 2025 | News
Harbour BioMed and AstraZeneca Announce $4.6B Global Collaboration on Next-Gen Multi-Specific Antibodies
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...
March 24, 2025 | News
Shanghai Moyom’s Aphranel® MagiCCrystal Becomes First NMPA-Approved CaHA Filler in China
Shanghai Moyom Biotechnology's high-profile brand, Aphranel® MagiCCrystal CaHA Filler, has officially obtained Class III Medical Device ...
March 24, 2025 | Regulatory
Parse Biosciences Welcomes South Australian Genomics Centre as First Certified Service Provider in Asia-Pacific
Parse Biosciences, a leader in scalable and affordable single-cell sequencing, is delighted to welcome the South Australian Genomics Centre (SAGC)&nbs...
March 24, 2025 | News
VantAI Introduces Neo-1, the First Unified Model for De Novo Molecular Generation and Structure Prediction
Neo-1 is the first model to unify de novo molecular generation and atomic-level structure prediction in a single model, by generating latent representa...
March 24, 2025 | News
Advanced Instruments to Acquire Nova Biomedical, Creating a Global Life Science Tools Powerhouse
Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, announ...
March 20, 2025 | News
Alphamab Oncology and CSPC’s Anti-HER2 ADC JSKN003 Secures Breakthrough Therapy Designation in China
Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic...
March 19, 2025 | News
SOPHiA GENETICS Surpasses Two Million Genomic Profiles Analyzed on AI-Powered Platform
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million...
March 19, 2025 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
